Home

Enchevêtrement outil marchande arv nature Enquête Le ciel Affiches

Immunology and the elusive AIDS vaccine | Nature
Immunology and the elusive AIDS vaccine | Nature

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

Scientists identify second HIV patient whose body appears to have rid  itself of the virus | Ragon Institute of Mass General, MIT, and Harvard
Scientists identify second HIV patient whose body appears to have rid itself of the virus | Ragon Institute of Mass General, MIT, and Harvard

JCI - The multifaceted nature of HIV latency
JCI - The multifaceted nature of HIV latency

HIV persistence in macrophages | Nature Medicine
HIV persistence in macrophages | Nature Medicine

HIV
HIV

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

Wallchart Request Immune Response to HIV
Wallchart Request Immune Response to HIV

Integrase inhibitors to treat HIV/Aids | Nature Reviews Drug Discovery
Integrase inhibitors to treat HIV/Aids | Nature Reviews Drug Discovery

Targeting early infection to prevent HIV-1 mucosal transmission | Nature
Targeting early infection to prevent HIV-1 mucosal transmission | Nature

HIV Virion | Biophysical chemistry laboratory
HIV Virion | Biophysical chemistry laboratory

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

Animal models for HIV/AIDS research | Nature Reviews Microbiology
Animal models for HIV/AIDS research | Nature Reviews Microbiology

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

HIV enters deep sleep in people who naturally control the virus
HIV enters deep sleep in people who naturally control the virus

HIV drug development: the next 25 years | Nature Reviews Drug Discovery
HIV drug development: the next 25 years | Nature Reviews Drug Discovery

Antibodies pose a double threat to HIV
Antibodies pose a double threat to HIV

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral  therapy | Nature
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy | Nature

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

HIV/AIDS : Collections : Supplements : Nature
HIV/AIDS : Collections : Supplements : Nature

Managing drug resistance in cancer: lessons from HIV therapy | Nature  Reviews Cancer
Managing drug resistance in cancer: lessons from HIV therapy | Nature Reviews Cancer

Past, present and future: 30 years of HIV research | Nature Reviews  Microbiology
Past, present and future: 30 years of HIV research | Nature Reviews Microbiology

HIV infection | Nature Reviews Disease Primers
HIV infection | Nature Reviews Disease Primers

Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4  lymphocytes | Nature Reviews Drug Discovery
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes | Nature Reviews Drug Discovery